Checked against FDA labeling, FDA safety communications and US sleep-medicine guidelines; current as of October 2026. Use this as preparation for a conversation with your prescriber, not as a diagnosis or a dosing guide.
Before comparing pills, compare nights. The Ambien vs Sonata choice depends less on which drug is “better” and more on where your sleep falls apart. Zolpidem (Ambien) and zaleplon (Sonata) are close chemical cousins, but one lasts a few hours and the other is mostly gone in about an hour. That difference makes each one a good fit for some sleep patterns and a poor fit for others.
So start with the short self-check below. Answer honestly, jot the answers down, and bring them to your appointment. The profiles that follow explain how each answer usually shapes the discussion.
The five-question sleep self-check
Think about a typical bad week over the past month, not your single worst night.
- Getting to sleep: Do you usually lie awake 30 minutes or more after lights out, then sleep reasonably well once you drift off?
- The 3 a.m. wake-up, plenty of night left: Do you often wake in the middle of the night and struggle to get back to sleep, with four or more hours still left before your alarm?
- The late wake-up, little night left: Do you wake and stay awake when fewer than four hours remain before you need to get up?
- Early waking: Do you wake an hour or more before you planned, feel unable to fall back asleep, and notice low mood or worry in those early hours?
- Next-day demands: Does your next morning include driving, operating machinery, caring for others, or work where even subtle slowness matters?
Mostly “yes” to question 1 points to sleep-onset insomnia. A “yes” to 2 or 3 points to sleep-maintenance problems. A “yes” to 4 deserves its own conversation, because early waking with low mood can be a sign of depression. A “yes” to 5 raises the stakes on any drug that lingers into the morning. Many people answer “yes” to more than one, and that is useful information too.
This checklist is a way to organize your story, not a test with a score. Insomnia can be driven by sleep apnea, restless legs, pain, reflux, anxiety, depression, medicines or alcohol, and a clinician should look for those before any sleeping pill is chosen.
Ambien vs Sonata at a glance
Here is a compact table drawn from current FDA labeling for immediate-release zolpidem tablets and zaleplon capsules. The doses shown are labeled doses only, not advice for you.
| Feature | Ambien (zolpidem IR) | Sonata (zaleplon) |
|---|---|---|
| First US approval | 1992 | 1999 |
| Labeled use | Short-term treatment of insomnia with difficulty falling asleep | Short-term treatment of insomnia; shortens time to sleep onset |
| Shown to increase total sleep or reduce awakenings? | Not the IR tablet’s labeled claim (CR version is) | No, per label |
| Usual labeled dose | 5 mg women; 5 or 10 mg men; max 10 mg | 10 mg most adults; 5 mg for some low-weight adults; 20 mg max |
| Age 65+ or debilitated | 5 mg | 5 mg; doses over 10 mg not recommended |
| Time to peak | About 1.6 hours | About 1 hour |
| Half-life | About 2.5 hours | About 1 hour |
| Heavy, high-fat meal | Slows onset | Delays peak about 2 hours and lowers it about 35% |
| Hours in bed required by label | 7 to 8 | 7 to 8 |
| Boxed warning | Complex sleep behaviors | Complex sleep behaviors |
| DEA schedule | IV | IV |
| Form | Tablet (generic widely available) | Capsule (brand discontinued; generics available) |
Two numbers explain most of the comparison: zaleplon’s half-life of about one hour versus zolpidem’s of about 2.5 hours. If you want to see how zolpidem clears over a full day, our article on how long Ambien stays in your system lays out the timeline.
Profile A: “I can’t fall asleep”
If question 1 was your main “yes,” both drugs are on the table. The 2017 American Academy of Sleep Medicine (AASM) guideline lists zaleplon and zolpidem among the drugs it suggests for sleep-onset insomnia. That recommendation is graded weak for both, which means modest benefit and a strong role for patient preference.
How zaleplon fits
Zaleplon is close to a pure “get me to sleep” drug. It peaks in about an hour and is largely cleared soon after. Its label is unusually candid: the drug shortens the time it takes to fall asleep for up to 30 days, but it has not been shown to increase total sleep time or reduce the number of awakenings. For someone whose nights go fine once sleep arrives, that narrow action can be a feature rather than a flaw.
Zaleplon also has a flexible-timing quirk. The label allows a dose immediately before bed or after you’ve gone to bed and found you can’t fall asleep. That second option can suit people who don’t need help every night and would rather wait and see.
How zolpidem fits
Immediate-release zolpidem is also labeled for sleep initiation, and its somewhat longer action gives more coverage of the first half of the night. In the large 2022 Lancet network meta-analysis described below, zolpidem was more effective than zaleplon for short-term treatment, although the certainty of that comparison ranged from moderate to very low. The trade-off is a longer tail, and with it a higher chance of next-morning effects, especially for women at higher doses.
One practical detail shapes the Ambien vs Sonata decision for this profile: how often the problem happens. If you struggle to fall asleep only two or three nights a week, a drug that can be taken after you’ve been in bed a while and still can’t sleep may let you skip unneeded doses. If it happens every night, the conversation usually shifts toward why. Long sleep-onset delays often come from a racing mind, a body clock that runs late, caffeine, screens or an irregular schedule. CBT-I and consistent wake times target those causes directly.
Discussion point for Profile A: “My problem is mostly getting to sleep. Is the shorter drug enough, or do I need a little more coverage?”
Profile B: “I wake in the middle of the night”
This is the profile where the Ambien vs Sonata question gets the most confused online. Many older articles say you can take Sonata in the middle of the night as long as at least four hours remain before waking. Studies have explored that idea, and the drug’s short half-life makes it sound plausible. But the current US zaleplon label does not say this. On DailyMed, the label says to take zaleplon at bedtime or after going to bed and having trouble falling asleep, and it warns that next-day impairment, including impaired driving, becomes more likely if it’s taken with less than a full night of sleep (7 to 8 hours) left. MedlinePlus gives the same advice.
The product that actually carries a “four hours remaining” instruction is a different one: a low-dose sublingual zolpidem tablet (1.75 mg for women, 3.5 mg for men) approved for middle-of-the-night waking. It was first sold as Intermezzo. That brand has been discontinued, but a generic zolpidem tartrate sublingual tablet is still listed on DailyMed. MedlinePlus’s zolpidem page explains that this version is taken only in bed, only when you can stay there at least four more hours, and no more than once a night.
For people who wake up most nights, the more common approach is a medicine that lasts through the night from bedtime: zolpidem CR, eszopiclone, low-dose doxepin or an orexin receptor antagonist. Our guides to Ambien vs Ambien CR and Ambien vs Lunesta compare those longer-acting options.
Discussion point for Profile B: “I usually wake around 3 a.m. Should I take something at bedtime that lasts longer, or is there a product meant for middle-of-the-night use? What should I never do when I wake up?”
Never take an extra dose of any sleep medicine in the middle of the night unless your prescriber has specifically told you to and the product is labeled for it. Taking a bedtime pill at 3 a.m. is one of the clearest routes to a dangerous morning drive.
Quick questions before the next profiles
Is Sonata weaker than Ambien?
For total sleep, generally yes. Zaleplon’s label limits its proven benefit to falling asleep faster, and the 2022 network meta-analysis found it less effective than zolpidem and eszopiclone in short-term treatment. “Weaker” also means shorter, though, and some people value that.
Can I take Sonata if Ambien gave me a complex sleep behavior?
No. Since 2019, the FDA has made eszopiclone, zaleplon and zolpidem all contraindicated in anyone who has had a complex sleep behavior on any one of them. Your prescriber would look at a different drug class or at non-drug treatment instead.
Does Sonata work faster than Ambien?
On average, zaleplon reaches its peak blood level slightly sooner, in about one hour versus about 1.6 hours for immediate-release zolpidem. Both start working sooner than their peaks, and a heavy meal delays either one. With zaleplon, the label reports a high-fat meal pushes the peak back about two hours.
Are both drugs addictive?
Both are Schedule IV controlled substances with potential for dependence, tolerance and withdrawal. The risk is higher with nightly long-term use, higher doses and a personal history of substance use. Our article on whether you can get addicted to Ambien explains the warning signs.
Profile C: “I need zero hangover”
If you answered “yes” to question 5, the morning matters as much as the night. Think of a nurse starting at 6 a.m., a truck driver, a parent doing the school run, or anyone whose job allows no margin for slowed reactions.
Where zaleplon has an edge
This is zaleplon’s strongest case. With a half-life of about an hour, very little drug should remain by morning after a full night in bed. The zaleplon label notes that in single-dose studies, memory and psychomotor impairment had faded by 3 to 4 hours after the dose, and that reports did not suggest more next-day sleepiness than placebo.
Where zolpidem needs more caution
Zolpidem’s labeling warns that higher morning blood levels after the 10 mg dose can increase the risk of next-day impairment of driving. That concern led the FDA to lower the recommended starting dose for women to 5 mg in 2013, because women clear the drug more slowly. Men may start at 5 mg or 10 mg. A lower dose and a full 7 to 8 hours in bed reduce the risk.
The fine print that applies to both
Even zaleplon’s label tells people not to drive or do anything dangerous until they feel fully awake, and the FDA has pointed out that all insomnia medicines can affect alertness the next morning. People are often poor judges of their own impairment. “Zero hangover” is a goal, not a guarantee.
Discussion point for Profile C: “I drive at 6 a.m. Which option leaves the least in my system, and how long should I wait the first few mornings before driving?”
Profile D: Older adult
Age changes the calculation for both drugs. Both labels call for 5 mg in older or debilitated adults, and zaleplon’s label advises against going above 10 mg in this group. The bigger concern is safety, not dosing. The 2023 American Geriatrics Society Beers Criteria list zolpidem and zaleplon among medicines older adults should avoid in most circumstances. The reasons are higher risks of falls, fractures, delirium, emergency visits and car crashes, for only small gains in sleep.
Zaleplon’s short action is sometimes pointed to as gentler for older people, and it may leave less behind by morning. But a nighttime bathroom trip an hour after the dose happens close to the drug’s peak, whichever Z-drug you take. Many falls happen in exactly that window. Our guide to Ambien in older adults covers fall-proofing, interactions and non-drug options in detail.
Other medicines matter more with age, too. Many older adults take something else that causes drowsiness, such as an opioid pain reliever, a muscle relaxant, gabapentin, an older antihistamine or a benzodiazepine for anxiety. Each one adds to the sedation from a Z-drug. Kidney and liver changes can also slow how fast drugs are cleared. In the Ambien vs Sonata comparison for older adults, a full medication review is often more useful than picking between the two. Bring every bottle, including over-the-counter sleep aids, to the visit.
Discussion point for Profile D: “Given my age and other medicines, should I be on a Z-drug at all? What can we try first, and how will we check whether it’s still needed?”
Why Sonata is less common now
If you have never heard a doctor mention Sonata, you are not alone. Several things have pushed it to the edges of US prescribing.
- The brand is gone. FDA Orange Book records list the Sonata brand capsules (approved in August 1999 under an application now held by Pfizer) as discontinued. Generic zaleplon capsules are still made: DailyMed lists labels from Ascend, Aurobindo, Bionpharma, Hikma, Rising, Unichem and several repackagers. Stock can vary from pharmacy to pharmacy, so it’s worth calling ahead.
- Narrow benefit. A drug that only shortens time to sleep, and isn’t proven to add total sleep, fits fewer patients than one that covers more of the night.
- Weaker showing in comparisons. In the 2022 network meta-analysis, zaleplon was less effective than benzodiazepines, eszopiclone, zolpidem and zopiclone in short-term treatment, though it was well tolerated.
- Newer competitors. Orexin receptor antagonists and low-dose doxepin gave prescribers non-GABA options for staying asleep.
- Familiarity. Zolpidem is one of the most widely prescribed sleep medicines in the US, so clinicians and pharmacists simply know it better.
So in day-to-day US practice, the zaleplon vs zolpidem matchup is a bit lopsided: one is a household name and the other is a specialist tool. Less common does not mean worse for you. For someone with pure sleep-onset trouble and a hard morning start, zaleplon may still be a reasonable option to raise.
Shared risks: the boxed warning and dependence
Whatever separates these drugs during the night, their most serious risks are the same.
Complex sleep behaviors
In April 2019, the FDA added a boxed warning to zolpidem, zaleplon and eszopiclone for complex sleep behaviors: sleepwalking, sleep-driving and other activities done while not fully awake. According to the FDA’s safety communication, the agency identified 66 cases with serious injuries between 1992 and 2018, 20 of them fatal. Most involved zolpidem, which partly reflects how widely it is used. These events can follow a single dose, even without alcohol. If one happens, stop the drug and call your prescriber. Our article on Ambien sleepwalking and sleep-driving explains the warning signs and how to make a home safer.
Dependence, rebound and withdrawal
Both drugs are Schedule IV. The zaleplon label on DailyMed describes mild rebound insomnia after stopping, mostly at 20 mg and gone by the second night. It also lists withdrawal symptoms that can include cramps, vomiting, sweating, shakiness and, rarely, seizures. Zolpidem carries similar warnings. After regular use, any reduction should be planned with your prescriber.
Sedation stacking
Alcohol, opioids, benzodiazepines, some antihistamines and other sedatives deepen the effects of both drugs and raise the risk of falls, slowed breathing and complex behaviors. With zaleplon, the label also flags cimetidine (an acid reducer), which raised zaleplon levels by about 85% in a study and calls for a lower starting dose.
Emergency help: call 911 for trouble breathing, unresponsiveness or injury. Poison Control is 1-800-222-1222. For substance use concerns, the SAMHSA National Helpline (1-800-662-4357) is free and confidential, and the 988 Suicide & Crisis Lifeline answers any time.
Evidence summary: what the research says about Ambien vs Sonata
Direct, modern head-to-head trials of zolpidem versus zaleplon are scarce. Most of what we know comes from placebo-controlled studies and from network meta-analyses, which compare drugs indirectly across many trials.
- The 2022 Lancet network meta-analysis (De Crescenzo and colleagues) covered 170 trials, 36 treatments and nearly 48,000 adults. As summarized by ACP Internist, zolpidem beat placebo and was more effective than zaleplon, melatonin and ramelteon in short-term treatment, though certainty ranged from moderate to very low. Zolpidem also caused more side effects than zaleplon and more dropouts due to side effects than placebo. Zaleplon was well tolerated, but the efficacy data did not allow firm conclusions.
- The AASM 2017 guideline suggests both zaleplon and zolpidem for sleep-onset insomnia and zolpidem (not zaleplon) for sleep maintenance. Every drug recommendation in that guideline is graded weak. The guideline summary also suggests against trazodone, diphenhydramine, melatonin and valerian for chronic insomnia.
- The American College of Physicians (2016) recommends cognitive behavioral therapy for insomnia as the first treatment for adults with chronic insomnia. It advises adding medication only through shared decision-making if CBT-I alone falls short, and notes that FDA approval covers short-term use.
Put together, the evidence on Ambien vs Sonata says zolpidem works somewhat better, zaleplon is somewhat gentler, and neither is a long-term answer on its own. Keep in mind that “on average across trials” and “for you” are not the same thing. Your response, side effects and morning schedule are data your prescriber can use, and a two-week sleep diary turns that experience into something concrete.
Alternatives worth raising
CBT-I first
Cognitive behavioral therapy for insomnia combines sleep restriction, stimulus control, work on unhelpful thoughts about sleep, and sleep-habit education. The ACP notes it can be delivered in person, in groups, by phone, online or through self-help books. It takes a few weeks of effort, but the skills keep working after treatment ends, which no pill can claim.
Low-dose doxepin for staying asleep
At very low doses (3 mg or 6 mg, sold as Silenor and as generics), the old antidepressant doxepin acts mainly as an antihistamine and is FDA-approved for trouble staying asleep. The AASM guideline suggests it for sleep-maintenance insomnia. It is not a controlled substance, though it still causes drowsiness and has its own interactions.
Orexin receptor antagonists
Suvorexant (Belsomra, approved 2014), lemborexant (Dayvigo, 2019) and daridorexant (Quviviq, 2022) work differently from Z-drugs. Instead of boosting GABA, they block orexin, a brain chemical that promotes wakefulness. They are approved for trouble falling asleep and/or staying asleep. They are Schedule IV and can still cause next-day sleepiness. In the 2022 network meta-analysis, lemborexant ranked alongside eszopiclone for overall profile, though its safety data were judged inconclusive.
Other comparisons
Some people are offered trazodone off-label or a benzodiazepine such as temazepam. Our comparisons of Ambien vs trazodone and Ambien vs Restoril walk through the trade-offs.
If this is you, talk to your prescriber about…
Use your self-check answers to find your row. Each right-hand cell is a topic to raise, not a prescription. Your clinician will weigh your health history, other medicines, and what you’ve already tried.
| If this is you | Talk to your prescriber about… |
|---|---|
| Can’t fall asleep, then sleep through; early or demanding mornings | Whether a short-acting option such as zaleplon fits, alongside CBT-I |
| Can’t fall asleep and want somewhat more first-half coverage | Immediate-release zolpidem at the lowest effective dose, with a full 7 to 8 hours in bed |
| Wake at 3 a.m. most nights with 4+ hours left | A bedtime option that lasts longer (zolpidem CR, eszopiclone, low-dose doxepin or an orexin antagonist), or whether a product labeled for middle-of-the-night use applies |
| Wake with under 4 hours left | Non-drug strategies; no bedtime sleep medicine should be taken at that hour |
| Wake very early with low mood or worry | Screening for depression or anxiety before any hypnotic |
| Drive or do safety-critical work early | Which option leaves the least behind, and a cautious plan for the first mornings |
| Age 65 or older | Whether any Z-drug is needed at all (Beers Criteria), fall prevention, and CBT-I first |
| Ever sleepwalked, sleep-ate or sleep-drove on a Z-drug | Non-Z-drug options only; all three Z-drugs are contraindicated |
| Snoring, gasping or morning headaches | A sleep apnea evaluation before sedatives |
| Using a sleep pill nightly for months | A supervised plan to reassess, taper if appropriate, and add CBT-I |
